Phase II study of long-term androgen suppression with bevacizumab and intensity-modulated radiation therapy (IMRT) in high-risk prostate cancer

Jacqueline Vuky, Huong T. Pham, Sarah Warren, Erika Douglass, Kasra Badiozamani, Berit Madsen, Alex Hsi, Guobin Song

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of long-term androgen suppression with bevacizumab and intensity-modulated radiation therapy (IMRT) in high-risk prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy